IL1A and autoimmune disease: Indeed IL-1, another potent mediator of inflammation involved in the pathogenesis of severe inflammatory and autoimmune diseases such as rheumatoid arthritis, has been neutralised using the IL-1R antagonist Anakinra with good safety record [52], although occasional tuberculosis reactivation have been reported [22,23].